Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield health care technology company, has named Northwestern Medicine as the initial site for its CLARITY trial. This study is aimed at demonstrating the clinical and economic value of Nociscan in spine surgery, particularly for chronic low back pain. The CLARITY trial is a randomized study designed to show…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here